Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-752-3 | CAS number: 13474-25-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral LD value of the test material was determined to be 4780 mg/kg bw (combined male and female).
The acute dermal LD value ot the test material analogue 3-methyl-1-vinyl-vinylimidazolium methosulfate was determined to be greater than 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well documented study report which meets basic scientific principles
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. k. Thomae GmbH, Biberach, Germany
- Weight at study initiation: animals of comparable weight (+/- 20 % of mean weight)
- Fasting period before study: 16 hours
- Housing: in groups of 5 separated by sex
- Diet: Kliba Labordiaet, Klingenthalermuele, Kaiseraugst, Switzerland, ad libitum
- Water:Tap water ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50, 38.3, 26.1 % (w/v)
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg - Doses:
- 2610, 3830, 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 males, 5 females per dose level
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: twice daily on working days, at least once on weekends and public holidays
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- LD50 values were determined by probit analysis according to Finney et al. (1971)
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 660 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 780 mg/kg bw
- 95% CL:
- 4 220 - 6 830
- Mortality:
- 5000 mg/kg dose level: 4/5 males, 2/5 females
3830 mg/kg dose level: 0/5 males, 1/5 females
2610 mg/kg dose level: 0/5 males, 0/5 females - Clinical signs:
- nothing abormal reported
- Body weight:
- nothing abnormal reported; all animals showed slight to normal body weight gain during the observation period
- Gross pathology:
- Deceased animals: general congestive hyperemia
Sacrificed animal: nothing abnormal detected
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 780 mg/kg bw
- Quality of whole database:
- Acceptable and well documented study similar to OECD TG No. 401.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2011-10-17 and 2012-01-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-conform study according to OECD guideline, EU method as well as EPA TG; for read-across justification, please refer to section 13
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Version / remarks:
- 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japan MAFF Testing Guideline of 12 Nosan No. 8147
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: male animals approx. 8 weeks, female animals approx. 12 weeks
- Weight at study initiation: male: 237.4 g (mean), female: 204.6 g (mean)
- Housing: single
- Diet: VRF1(P); SDS Special Diets Services, 67122 Altrip,Germany
- Water: Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 – 70
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 40 cm2
- % coverage: at least 10% of the body surface
- Type of wrap: 4 layers of absorbent gauze and stretch bandage
REMOVAL OF TEST SUBSTANCE
- Washing: done with warm water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount applied: 3.33 mL/kg bw
- Concentration: 60 g/100 mL
- Constant volume or concentration used: no data
- The solid test substance was dissolved in deionized water to contain a solution. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observation and weighing: before administration (day 0), weekly thereafter and on the last day of observation
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred.
- Clinical signs:
- No systemic and local clinical signs were observed during clinical examination.
- Body weight:
- The mean body weight of the male animals increased within the normal range throughout the study period. The mean body weight of the female animals did not adequately increase during the first post-exposure observation week, probably due to the bandage procedure, but increased during the second week within the normal range, with the exception of one female which still showed stagnation of body weight.
- Gross pathology:
- No macroscopic pathologic abnormalities were noted in the animals (5 males and 5 females) examined on the last day of observation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP-conform study in accordance with OECD guideline, EU method, US EPA guidline and Japan Maff guideline. Test substance analogue was used.
Additional information
Acute oral toxicity
An acute oral toxicity study in female and male rats was performed to estimate the potential acute hazard after single administration of the test substance. A solution of the test material was exposed by gavage to the following doses: 5000, 3830 or 2610 mg/kg bw. The animals fasted 16 hours before admistration, but water was available ad libitum. The animals were observed over a period of 14 days. Signs and symptoms were recorded several times on the day of admistration and at least once each workday. Check for moribund and dead animals twice each workday and once on holiday. No clinical signs were reported. All animals showed slight to normal body weight gain during the observation period. Gross pathology was performed. While deceased animals showed general congestive hyperemia, sacrificed animals showed no abnormalities of the organs. The follwing rate of death were observed after 14 days:
2610 mg/kg bw: 0/10 animals
3830 mg/kg bw: 1/10 animals
5000 mg/kg bw: 6/10 animals.
In conclusion, the acute oral LD50 value of the test material was found to be 4780 mg/kg bw (combined male and female).
Acute dermal toxicity
In an acute dermal toxicity study (Limit Test), young adult Wistar rats (5 males and 5 females) were dermally exposed to a single dose of 2000 mg/kg bw of the test substance analogue 3 -methyl-1-vinyl-1 H-imidazolium methyl sulfate (as solution in doubly deionized water) to the clipped skin (dorsal and dorso-lateral parts of the trunk) and covered by semi-occlusive dressing for 24 hours. The application area comprised at least 10% of the total body surface area. The animals were observed for 14 days. The following test substance-related observations were recorded:
- No signs of systemic toxicity or skin effects.
- The mean body weight of the male animals increased within the normal range throughout the study period.
- The mean body weight of the female animals did not adequately increase during the first post-exposure observation week, probably due to the bandage procedure, but increased during the second week within the normal range, with the exception of one female which showed still stagnation of body weight..
- No macroscopic pathologic abnormalities were noted in the animals examined at the end of the study.
- No mortality occurred.
Accordingly, the acute dermal median lethal dose (LD50) was determined to be greater than 2000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
Only one reliable study.
Justification for selection of acute toxicity – dermal endpoint
Only one reliable study.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the test substance is not considered to be classified for acute oral and dermal toxicity under Directive 67/548/EEC, as amended for the 31st time in Directive 2009/2/EG.
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the test substance is not considered to be classified for acute oral and dermal toxicity under Regulation (EC) No 1272/2008, as amended for the sixth time in Regulation EC 605/2014.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.